Literature DB >> 32242749

Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?

Concepción Peiró1,2, Salvador Moncada3.   

Abstract

Entities:  

Keywords:  angiotensin receptor blockers; angiotensins; ards, human; lung inflammation; sars coronavirus; treatment; vascular endothelial cells

Mesh：

Substances：

Year:  2020        PMID： 32242749      PMCID： PMC7243666          DOI： 10.1161/CIRCULATIONAHA.120.047297

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

Review 1.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

2.  Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Authors:  Lei Fang; George Karakiulakis; Michael Roth
Journal:  Lancet Respir Med       Date:  2020-03-11       Impact factor: 30.700

3.  Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target.

Authors:  Haibo Zhang; Josef M Penninger; Yimin Li; Nanshan Zhong; Arthur S Slutsky
Journal:  Intensive Care Med       Date:  2020-03-03       Impact factor: 17.440

4.  A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.

Authors:  Keiji Kuba; Yumiko Imai; Shuan Rao; Hong Gao; Feng Guo; Bin Guan; Yi Huan; Peng Yang; Yanli Zhang; Wei Deng; Linlin Bao; Binlin Zhang; Guang Liu; Zhong Wang; Mark Chappell; Yanxin Liu; Dexian Zheng; Andreas Leibbrandt; Teiji Wada; Arthur S Slutsky; Depei Liu; Chuan Qin; Chengyu Jiang; Josef M Penninger
Journal:  Nat Med       Date:  2005-07-10       Impact factor: 53.440
  4 in total
  18 in total

Review 1.  Perspectives: potential therapeutic approach with inhalation of ACE2-derived peptides for SARS-CoV-2 infection.

Authors:  Rossella Talotta; Erle S Roberston
Journal:  Am J Clin Exp Immunol       Date:  2020-12-15

Review 2.  Post-Coronavirus Disease 2019 Pulmonary Fibrosis: Wait or Needs Intervention.

Authors:  Hee-Young Yoon; Soo-Taek Uh
Journal:  Tuberc Respir Dis (Seoul)       Date:  2022-06-20

3.  Angiotensin 1-7 Stimulates Proliferation of Lung Bronchoalveolar Progenitors-Implications for SARS-CoV-2 Infection.

Authors:  Andrzej K Ciechanowicz; Wen Xin Lay; Jefte Prado Paulino; Erika Suchocki; Susanne Leszczak; Christian Leszczak; Magdalena Kucia
Journal:  Cells       Date:  2022-07-02       Impact factor: 7.666

4.  COVID-19 and the renin-angiotensin system (RAS): A spark that sets the forest alight?

Authors:  O J Wiese; B W Allwood; A E Zemlin
Journal:  Med Hypotheses       Date:  2020-09-03       Impact factor: 1.538

Review 5.  Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection.

Authors:  Maira Soto; Gere diZerega; Kathleen E Rodgers
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Oct-Dec       Impact factor: 1.636

6.  Angiotensin-(1-7) and Obesity: Role in Cardiorespiratory Fitness and COVID-19 Implications.

Authors:  Daisy Motta-Santos; Robson A S Santos; Sérgio Henrique Sousa Santos
Journal:  Obesity (Silver Spring)       Date:  2020-09-01       Impact factor: 9.298

Review 7.  Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies.

Authors:  Alessandro Allegra; Vanessa Innao; Andrea Gaetano Allegra; Caterina Musolino
Journal:  Ann Hematol       Date:  2020-07-15       Impact factor: 3.673

Review 8.  The dilemma of renin-angiotensin system inhibitors in coronavirus disease 2019 (COVID-19): insights into lung fluid handling and gas exchange in heart failure patients.

Authors:  Marco Guazzi; Alice Moroni
Journal:  Eur J Heart Fail       Date:  2020-06-27       Impact factor: 17.349

9.  Vitamin D and SARS-CoV-2 infection-evolution of evidence supporting clinical practice and policy development : A position statement from the Covit-D Consortium.

Authors:  Daniel M McCartney; Paula M O'Shea; John L Faul; Martin J Healy; Greg Byrne; Tomás P Griffin; James Bernard Walsh; Declan G Byrne; Rose Anne Kenny
Journal:  Ir J Med Sci       Date:  2020-11-21       Impact factor: 2.089

Review 10.  SARS-COV-2 (COVID-19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments.

Authors:  Hakan Parlakpinar; Mehmet Gunata
Journal:  Cell Biochem Funct       Date:  2020-09-29       Impact factor: 3.963
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.